| Rationale and design of a randomized placebo-controlled clinical trial assessing the renoprotective effects of potassium supplementation in chronic kidney disease M Gritter, L Vogt, SMH Yeung, RD Wouda, CRB Ramakers, MH de Borst, ... Nephron 140 (1), 48-57, 2018 | 56 | 2018 |
| Effects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney Disease M Gritter, R Wouda, S Yeung, M Wieers, F Geurts, M de Ridder, ... Journal of the American Society of Nephrology, 2022 | 39 | 2022 |
| Fibroblast growth factor 23 and mortality in patients with type 2 diabetes and normal or mildly impaired kidney function SMH Yeung, SH Binnenmars, CM Gant, G Navis, RT Gansevoort, ... Diabetes care 42 (11), 2151-2153, 2019 | 30 | 2019 |
| Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony SMH Yeung, SJL Bakker, GD Laverman, MH De Borst Current Diabetes Reports 20 (10), 1-9, 2020 | 26 | 2020 |
| Phosphate and fibroblast growth factor 23 in diabetes A van der Vaart, SMH Yeung, PR van Dijk, SJL Bakker, MH de Borst Clinical Science 135 (14), 1669-1687, 2021 | 20 | 2021 |
| Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study JK Humalda, SMH Yeung, JM Geleijnse, L Gijsbers, IJ Riphagen, ... The Journal of Clinical Endocrinology & Metabolism 105 (9), e3246-e3256, 2020 | 17 | 2020 |
| Net endogenous acid excretion and kidney allograft outcomes SMH Yeung, AW Gomes-Neto, MCJ Osté, E van den Berg, ... Clinical Journal of the American Society of Nephrology 16 (9), 1398-1406, 2021 | 14 | 2021 |
| Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study SH Binnenmars, GE Hoogslag, SMH Yeung, FP Brouwers, SJL Bakker, ... Journal of the American Heart Association 11 (15), e024952, 2022 | 13 | 2022 |
| Pretransplant NT-proBNP, Dialysis Vintage, and Posttransplant Mortality in Kidney Transplant Recipients SMH Yeung, M van Londen, U Nakshbandi, MY Said, MF Eisenga, ... Transplantation 104 (10), 2158-2165, 2020 | 9 | 2020 |
| Potassium: poison or panacea in chronic kidney disease? SMH Yeung, L Vogt, JI Rotmans, EJ Hoorn, MH de Borst Nephrology Dialysis Transplantation 34 (2), 175-180, 2019 | 4 | 2019 |
| Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort SMH Yeung, EJ Hoorn, JI Rotmans, RT Gansevoort, SJL Bakker, L Vogt, ... Nutrients 13 (12), 4532, 2021 | 2 | 2021 |
| Short-Term Effects of Potassium Chloride Supplementation on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease S Yeung, M Gritter, R Wouda, S Bakker, J van Zanden, J Rotmans, ... Clinical Journal of the American Society of Nephrology, 2022 | 1 | 2022 |
| Low Urinary Potassium Excretion is Associated With Higher Risk of All-Cause Mortality in Patients With Type 2 Diabetes: Results of the Dutch DIALECT Cohort SMH Yeung, MM Oosterwijk, M Poelstra, CM Gant, JI Rotmans, EJ Hoorn, ... The Journal of Nutrition, 2022 | 1 | 2022 |
| Urinary Potassium Excretion and Mortality Risk in Community-Dwelling Individuals with and without obesity SMH Yeung, A Nooteboom, EJ Hoorn, JI Rotmans, L Vogt, RA de Boer, ... The American Journal of Clinical Nutrition, 2022 | 1 | 2022 |
| MO443 EFFECTS OF SHORT-TERM POTASSIUM CHLORIDE SUPPLEMENTATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE M Gritter, R Wouda, SMH Yeung, L Vogt, M De Borst, J Rotmans, E Hoorn Nephrology Dialysis Transplantation 36 (Supplement_1), gfab090. 005, 2021 | | 2021 |
| Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort. Nutrients 2021, 13, 4532 SMH Yeung, EJ Hoorn, JI Rotmans, RT Gansevoort, SJL Bakker, L Vogt, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| HIGHER DIETARY ACID LOAD IS ASSOCIATED WITH INCREASED RISK FOR KIDNEY FUNCTION DECLINE AND GRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS SMH Yeung, AW Gomes-Neto, MCJ Oste, E Van den Berg, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 1940-1940, 2020 | | 2020 |
| P1625 HIGHER DIETARY ACID LOAD IS ASSOCIATED WITH INCREASED RISK FOR KIDNEY FUNCTION DECLINE AND GRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS SMH Yeung, AW Gomes-Neto, M CJ Osté, E Van den Berg, ... Nephrology Dialysis Transplantation 35 (Supplement_3), gfaa142. P1625, 2020 | | 2020 |
| Potassium supplementation in chronic kidney disease patients-a randomized double blind placebo control study [copy] MH de Borst, SMH Yeung | | |
